Disseminated Mycobacterium avium infection in AIDS is associated with high tissue burdens (109-10i1 mycobacteria/g tissue) of organism. The basis for the extraordinary susceptibility of AIDS to M. avium infection is unclear. HIV or its constituents may alter mononuclear phagocyte functions resulting in enhanced intracellular M. avium growth. The effects of an envelope glycoprotein (gpl20), a transmembrane protein (pl21), and core proteins of HIV-1 on M. avium infection of human monocytes were examined. Preculturing monocytes with gp120 inhibited M. avium phagocytosis and consistently enhanced intracellular growth of six M. avium strains. Pretreatment with p121, gagS, or p24 did not inhibit phagocytosis nor enhance intracellular growth of M. avium. Incubation of gpl20 with soluble CD4 before addition to monocyte cultures or pretreatment of monocytes with OKT4A abrogated gp120 effects on M. avium phagocytosis and intracellular growth. gp120 also augmented cytokine production by infected monocytes. These results suggest that gpl20, but not p121 or core proteins, modulate monocyte phagocytosis and enhance intracellular growth of M. avium at least in part through monocyte CD4 receptors. Direct effects of HIV-1 products may, therefore, contribute to the diathesis of AIDS to develop disseminated M. avium infection and to the extensive replication of the organisms within tissue macrophages. (J. Clin. Invest. 1994. 93:885-891.)
Introduction
Mycobacterium avium is an intracellular pathogen that predominantly parasitizes mononuclear phagocytes, and is the most frequent cause of disseminated infection in patients with AIDS (1, 2) . Disseminated M. avium disease usually occurs late in the course of AIDS and is associated with severe immunosuppression. Although only 3-4% ofAIDS patients have disseminated M. avium infection as their initial opportunistic infection, 46-56% of AIDS patients have evidence of disseminated M. avium infection at the time of death (3, 4) . High tissue burdens ofM. avium ( 109-101 acid-fast bacilli [AFB] ' / g tissue) have been documented in AIDS patients (5) . The pathophysiologic mechanisms underlying the extraordinary intracellular growth of this organism are unknown.
Mononuclear phagocytes, including monocytes and tissue macrophages, are important effector cells against mycobacteria and other intracellular pathogens. Unlike CD4 lymphocytes, which are the major reservoir of HIV-1, < 1% of monocytes and up to 10% of tissue macrophages obtained from AIDS patients are infected with HIV-1 (6, 7) , implying that factors other than direct infection with HIV-1 are involved in the exuberant intracellular growth ofM. avium in patients with AIDS.
The initial step in HIV infection ofT cells and monocytes is mediated by specific binding of the viral envelope protein gp 120 to the CD4 molecule (8, 9) . Soluble CD4 (sCD4) binds to gpl20 and blocks HIV-1 infection of human cells ( 10, 11 ) . In vitro studies of the effects of HIV and its envelope protein, gp 120, on macrophage function have generated conflicting results. Infection with HIV-1 in vitro enhances IL-1 and TNF-a expression by human monocytic cell lines stimulated with LPS ( 12, 13) . In early reports, live and killed HIV induced expression of IL-1, IL-6, and TNF-a by human monocytes ( 14, 15) . Native, but not recombinant, gp 120 induces cytokine expression by monocytes from healthy subjects (16) . In another study, however, mononuclear cells stimulated with HIV or gp 120 failed to produce cytokines when effects of LPS were excluded ( 17) . HIV gp 120 also inhibited monocyte chemotaxis via downregulation of ligand receptors ( 18 Monocyte separation and culture. PBMC were isolated from heparinized venous blood obtained from HIV-negative healthy subjects and suspended in RPMI 1640 (M. A. Whittaker Bioproducts, Walkersville, MD) supplemented with 5% autologous unheated serum (complete medium). Three 50-il PBMC (107/ml) suspensions were placed in 35-mm petri dishes and incubated for 60 min at 370C. Nonadherent cells were removed by washing the plates two times with prewarmed medium. The monocytes were precultured with or without recombinant HIV-I protein for 2 d in complete medium at 370C, 5% CO2 in air and then infected with 1.5 ml ofM. avium suspension ( I0' bacteria/ml in complete medium) for 60 min at 370C. The dishes were washed four times with prewarmed medium to remove extracellular bacteria and were cultured in 2 ml of complete medium for 7 d. Representative plates were fixed with methanol for assessment of phagocytosis. Samples were harvested at time 0 (immediately after infection) and 7 d after infection for CFU assay. The density of monocyte monolayers as assessed by counting cell nuclei with naphthol blue black staining ( 19) was comparable between control and gp 1 20-pretreated cultures throughout the 7-d culture period.
Most M. avium growth using this experimental system is intracellular and not due to adherence ( 19 Counting ofAFB. Immediately after infection with M. avium, petri dishes were fixed with methanol and stained by Kinyoun's modified acid-fast method. The number ofintracellular mycobacteria was determined by counting AFB within monocytes by oil immersion light microscopy at X 1,000. The percentage of monocytes infected with 2 1 AFB and the total number of AFB per 100 monocytes were calculated as described previously ( 19, 21 ) and the data reported as mean±SEM.
Counting of CFU. The number of M. avium in each sample was assessed by CFU assay as described previously ( 19, 21 ) . Monocytes were lysed by adding 1.1 ml of Middlebrook 7H9 medium and 0.4 ml of 0.25% SDS in PBS to each petri plate for 10 min. Monocyte lysates were then transferred to tubes containing 0.5 ml of20% BSA to neutralize the SDS, sonicated for 20 s to assure a single-cell suspension of mycobacteria, and serially 10-fold diluted in 7H9 medium. 10-,ul aliquots of each dilution were plated in triplicate on Middlebrook 7H 10 agar supplemented with oleic acid-albumin-dextrose-catalase (Difco Laboratories, Detroit, MI). The agar plates then were incubated at 37°C for [4] [5] [6] [7] Expression ofcytokine mRNA. Adherent monocytes were precultured in a 60-mm petri dish ( 1007; Falcon Labware, Oxnard, CA) with or without gpl20 (1 ,g/ml) for 2 d and then infected with M. avium. Monocytes were cultured for 24 h. Total RNA was extracted by the guanidinium cesium method (22) . RNA was electrophoretically separated on a 1% agarose-2 M formaldehyde gel, and transferred to nylon membranes (GIBCO BRL, Gaithersburg, MD). RNA then was crosslinked to the membrane using UV light (Stratagene, La Jolla, CA).
Prehybridization was done at 420C in a solution containing 50% formamide, 5X Denhardts' solution ( 100X = 2% Ficoll, 2% polyvinylpyrrolidone, 2% bovine serum albumin), 5X SSC, and 0.5% SDS, with heat denatured salmon sperm DNA (100 ,g/ml). Hybridization was performed in the same solution to which dextran sulfate ( 15% final concentration) was added and contained a 32P-labeled cDNA probe for human IL-la, IL-6, or TNF-a (provided by Dr. P. Lomedico, Hoffman-La Roche, Inc., Nutley, NJ). Membranes were washed with 2x SSC and 1% SDS at 60'C for 1 h with agitation, and exposed to XAR-5 film (Kodak Laboratories, Rochester, NY) at -70°C with an intensifying screen.
Statistical analysis. The significance of differences between cultures with or without HIV-I protein was calculated by the paired Student's t test.
Results
Effect of gpJ20 on monocyte phagocytosis of M. avium. To investigate whether HIV-1 envelope protein gpl20 altered monocyte effector functions against M. avium, monocytes obtained from healthy HIV-negative subjects were precultured with recombinant HIV-1 gpl20 (0-1.0 ,g/ml, final concentration) for 2 d and then infected with virulent M. avium strain LRl 14SmT. The efficiency of phagocytosis of M. avium by monocytes was assessed by enumerating intracellular AFB by light microscopy. Maximal effects of gp120 in decreasing phagocytosis of M. avium were observed at a concentration of 0.2 jig/ml (data not shown). Pretreatment of monocytes with gpl20 (0.2 ,g/ml) significantly inhibited phagocytosis of M. avium by human monocytes (P < 0.001 ) ( Table I ). To assess whether these effects on M. avium phagocytosis were unique for gpl 20, we tested additional HIV structural proteins, gag5 and pl21. Monocytes were pretreated with various doses (ranging from 0.05 to 1.0 ,ug/ml) of recombinant gag5 or recombinant p1 21 for 2 d and then infected with M. avium strain LR1 14SmT. Pretreatment with gag5 or p121 did not alter monocyte phagocytosis (Table I) . To evaluate whether the observed effects of gp 120 on M. avium phagocytosis were due to residual contaminants derived from the baculovirus expression system, we compared the effects ofgp 120 and HIV core protein p24, both expressed in an identical baculovirus system, on M. avium phagocytosis. Two preparations of recombinant gp 120 (Repligen, Boston, MA; and American Bio-Technologies, Cambridge, MA) had comparable effects in decreasing monocyte phagocytosis of M. avium. Phagocytosis of M. avium after pretreatment with p24 also expressed in a baculovirus vector system was, however, comparable to control cultures (Table   II ). These data suggest that the effects of gp 120 observed were not due to contaminants from the expression vector. Blocking ofgpl20 effects by sCD4 and OKT4A antibody.
HIV-1 gp 120 binds specifically to CD4 receptors on helper T lymphocytes. Incubation with sCD4 or OKT4A monoclonal (Fig. 2) . Mon cyte pretreatment with OKT4 before incubation with gpl also failed to abrogate the effect of gp120 in inhibiting I avium phagocytosis (Table IV) . Pretreatment of monocyl with OKT4 or OKT4A alone had no effect on M. avium phag cytosis. Preincubation ofgpl 20 with sCD4 also neutralized t ability of gpl 20 to enhance intracellular growth of M. avid (Table V) . sCD4, OKT4, or OKT4A alone had no effect 4 (Table VI) and cytokine-specific mRNA expression ( Fig. 3) were assessed. As shown in cytes stimulated with M. avium alone (P < 0.05 for IL-la and ,, and P < 0.01 for TNF-a and IL-6). TNF-a-, IL-6-, and IL-lra-specific mRNA expression in monocytes pretreated with gpl20 and then stimulated with M. avium were assayed by Northern blot analysis (Fig. 3) . Stimulation ofmonocytes with M. avium induced significant cytokinespecific mRNA expression above baseline. Pretreatment with gpl20 followed by M. avium stimulation resulted in higher mRNA expression than stimulation with gp 120 or M. avium alone. These results indicate that gp 120 augments cytokine production by monocytes infected with M. avium, a property that may result in increased intracellular growth of the organisms.
Discussion
The late stages of HIV infection are characterized by repeated, often incurable opportunistic infections in the setting of progressive immunosuppression with declining cell-mediated host immunity and increased HIV replication. Considerable controversy exists regarding whether HIV or specific viral constituents or products directly impair(s) host immune defenses against opportunistic pathogens or whether the increased occurrence of these infections is due to indirect effects of HIV mediated by progressive depletion ofthe CD4 helper T cell population.
Disseminated M. avium disease is common in the late stages of HIV infection. In (27, 28) , although cytokine production and Fc and C3 receptor-mediated phagocytosis were defective (29, 30) . We and others demonstrated preserved effector cell function ofmonocytes obtained from AIDS patients against in vitro M. avium infection (20, 21 ). In contrast, Crowle et al. (31 ) reported that monocyte-derived macrophages of AIDS patients exhibited enhanced intracellular M. avium growth.
Direct effects of HIV infection on human monocyte effector functions against M. avium have been studied by in vitro HIV infection of monocytes from healthy subjects. Dual infection of human monocyte-derived macrophages with HIV and M. avium did not alter intracellular mycobacterial growth in short-term culture (32) , but increased permissiveness of HIV-1-infected macrophages for intracellular M. avium growth was present after 14 d of culture (33) . In vitro monocyte infection with HIV may not, however, accurately reflect conditions in the tissues of patients with AIDS. HIV infection of monocytes and tissue macrophages in AIDS patients is quantitatively lower than T cells (6, 7) . Therefore, the effects of HIV-1 infection on mononuclear phagocyte effector functions against M. avium are likely to be indirect. Constituents of HIV-1 may increase the pathogenicity of AIDS-associated opportunistic infectious agents by interfering with the host effector mechanisms.
HIV-infected lymphocytes and monocytes release viral proteins such as gpl 20 into culture media in vitro, and HIV gp 120 has been detected in serum obtained from AIDS patients in concentrations ranging from 0.001 to 0.1 sg/ml (34) . We examined the dose-response activity ofgp 120 on both phagocytosis and intracellular growth of M. avium; optimal responses occurred at a concentration of 0.2 ,gg/ml, twofold higher than the maximal levels found in serum from patients with AIDS. However, HIV replication and viral burden as assessed by RNA PCR and in situ tissue hybridization studies, respectively, were much greater in lymphoid tissue mononuclear cells than in PBMC at all stages of HIV infection (35) ; it is likely, there- fore, that tissue levels of gpl20 are substantially higher than those reported in serum, and in the range demonstrated to modulate effector function against M. avium.
HIV-1 gpl20 specifically binds to CD4 receptors (8, 9) , and may activate monocytes via this interaction ( 14) . Binding of gpl20 to human monocytes has been demonstrated (24) . Our data demonstrating that sCD4 and OKT4A, but not OKT4, abrogated the effects of gp 120 indicate that the effects ofgp120 on phagocytosis and intracellular growth ofM. avium are specifically mediated, at least in part, via CD4 receptors on the monocyte surface. Other HIV-1 proteins, including transmembrane envelope and core proteins, did not show these effects on monocyte effector functions against M. avium infection. The effects observed in this study may be specific for gp 120. In a preliminary report, Wagner et al. (36) reported that HIV-I gp 120 reduced the phagocytosis and enhanced the intracellular growth of Cryptococcus neoformans, another opportunistic pathogen in AIDS patients, by alveolar macrophages. It is not clear whether the effects of gp 120 on effector function against M. avium and C. neoformans are mediated similarly.
Several investigators have shown that gpl20 .activates human monocytes to express cytokines ( 14, 16) . M. avium infection also induces cytokine production by mononuclear phagocytes such as IL-1, IL-6, IL-10, TNF-a, and TGF-# (26, 37, 38) . We have previously reported that certain cytokines such as IL-la and IL-6 enhanced intracellular and extracellular M. avium growth (25) and Bermudez and Champsi (37, 38) have shown that TGF-,3 and IL-10, immunosuppressive cytokines, enhanced intracellular M. avium growth. In this study, pretreatment ofhuman monocytes with gpl20 synergistically augmented production of IL-1, TNF-a, and IL-6 when monocytes were infected with M. avium. Induction of these and other cytokines by HIV-1 proteins might modulate the ability of mononuclear phagocytes to limit intracellular growth of this pathogen. Unfavorable alterations in the dynamic local balance of these mycobacterial growth-inhibiting and growth-enhancing factors may lead to increased intracellular replication of this pathogen.
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